<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">03080</article-id><article-id pub-id-type="doi">10.7554/eLife.03080</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biophysics and Structural Biology</subject></subj-group></article-categories><title-group><article-title>Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetine</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-13189"><name><surname>Wong</surname><given-names>Wilson</given-names></name><aff><addr-line><named-content content-type="department">Division of Infection and Immunity</named-content></addr-line>, <institution>Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3345"><name><surname>Bai</surname><given-names>Xiao-chen</given-names></name><aff><institution>Medical Research Council Laboratory of Molecular Biology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13190"><name><surname>Brown</surname><given-names>Alan</given-names></name><aff><institution>Medical Research Council Laboratory of Molecular Biology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3438"><name><surname>Fernandez</surname><given-names>Israel S</given-names></name><aff><institution>Medical Research Council Laboratory of Molecular Biology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13191"><name><surname>Hanssen</surname><given-names>Eric</given-names></name><aff><addr-line><named-content content-type="department">Electron Microscopy Unit</named-content></addr-line>, <institution>Bio21 Molecular Science and Biotechnology Institute, University of Melbourne</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13192"><name><surname>Condron</surname><given-names>Melanie</given-names></name><aff><addr-line><named-content content-type="department">Division of Infection and Immunity</named-content></addr-line>, <institution>Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13193"><name><surname>Tan</surname><given-names>Yan Hong</given-names></name><aff><addr-line><named-content content-type="department">Division of Infection and Immunity</named-content></addr-line>, <institution>Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13194"><name><surname>Baum</surname><given-names>Jake</given-names></name><aff><addr-line><named-content content-type="department">Department of Life Sciences</named-content></addr-line>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3361"><name><surname>Scheres</surname><given-names>Sjors HW</given-names></name><aff><institution>Medical Research Council Laboratory of Molecular Biology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country><email>scheres@mrc-lmb.cam.ac.uk</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1125"><name><surname>Kühlbrandt</surname><given-names>Werner</given-names></name><role>Reviewing editor</role><aff><institution>Max Planck Institute of Biophysics</institution>, <country>Germany</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>06</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e03080</elocation-id><supplementary-material><ext-link xlink:href="elife-03080-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>14</day><month>04</month><year>2014</year></date><date date-type="accepted"><day>06</day><month>06</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Wong et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Wong et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Malaria inflicts an enormous burden on global human health. The emergence of parasite resistance to front-line drugs has prompted a renewed focus on the repositioning of clinically approved drugs as potential anti-malarial therapies. Antibiotics that inhibit protein translation are promising candidates for repositioning. We have solved the cryo-EM structure of the cytoplasmic ribosome from the human malaria parasite, Plasmodium falciparum, in complex with emetine at 3.2 Å resolution. Emetine is an anti-protozoan drug used in the treatment of ameobiasis that also displays potent anti-malarial activity. Emetine interacts with the E-site of the ribosomal small subunit and shares a similar binding site with the antibiotic pactamycin, thereby delivering its therapeutic effect by blocking mRNA/tRNA translocation. As the first cryo-EM structure that visualizes an antibiotic bound to any ribosome at atomic resolution, this establishes cryo-EM as a powerful tool for screening and guiding the design of drugs that target parasite translation machinery.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>